aMe17b (R), n=2 cell(s)

Main group: Visual Centrifugal Neurons; Neurotransmitter consensus prediction: GABA

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 - - - - 69.5 787.0 30.5 - - - 887.0
1 - - - - 159.0 1103.0 26.5 - - - 1288.5
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - - - -
Pre - - - - - - - -
  AME
0 130.0
1 2.5
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 673.0
1 11.5

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses:1774
Number of pre synapses:2577
Number of output connections:9075
Coverage factor:1.4
Columnar completeness:0.71
Area completeness:0.84
Cell size (columns):450

Lobula

Number of post synapses:0
Number of pre synapses:0
Number of output connections:0
Coverage factor:0
Columnar completeness:0
Area completeness:0
Cell size (columns):0

Lobula Plate

Number of post synapses:0
Number of pre synapses:0
Number of output connections:0
Coverage factor:0
Columnar completeness:0
Area completeness:0
Cell size (columns):0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#aMe17b (R) % % cumu.
0 Tm5a (R) ACh 1,055 527.5 50.7% 50.7%
1 aMe17a (R) Glu 150 75.0 7.2% 57.9%
2 aMe9 (R) ACh 92 46.0 4.4% 62.4%
3 Cm4 (R) Glu 89 44.5 4.3% 66.6%
4 aMe6b (R) ACh 78 39.0 3.8% 70.4%
5 aMe6c (R) Glu 63 31.5 3.0% 73.4%
6 Dm8a (R) Glu 50 25.0 2.4% 75.8%
7 aMe5 (R) ACh 36 18.0 1.7% 77.5%
8 Tm5b (R) ACh 27 13.5 1.3% 78.8%
9 Mi15 (R) ACh 25 12.5 1.2% 80.0%
10 MeTu3c (R) ACh 23 11.5 1.1% 81.2%
11 aMe9 (L) ACh 18 9.0 0.9% 82.0%
12 Dm2 (R) ACh 18 9.0 0.9% 82.9%
13 Cm1 (R) ACh 16 8.0 0.8% 83.7%
14 MeVP43 (R) ACh 16 8.0 0.8% 84.4%
15 MeVP23 (R) unclear 15 7.5 0.7% 85.1%
16 Tm39 (R) ACh 13 6.5 0.6% 85.8%
17 Dm8b (R) Glu 11 5.5 0.5% 86.3%
18 Tm5Y (R) ACh 11 5.5 0.5% 86.8%
19 aMe10 (R) ACh 10 5.0 0.5% 87.3%
20 aMe10 (L) ACh 10 5.0 0.5% 87.8%
21 Cm31b (R) GABA 9 4.5 0.4% 88.2%
22 LoVCLo3 (L) OA 9 4.5 0.4% 88.7%
23 TmY21 (R) ACh 9 4.5 0.4% 89.1%
24 aMe2 (R) Glu 8 4.0 0.4% 89.5%
25 Cm2 (R) ACh 8 4.0 0.4% 89.9%
26 Tm29 (R) Glu 8 4.0 0.4% 90.2%
27 Dm9 (R) Glu 7 3.5 0.3% 90.6%
28 MeTu1 (R) ACh 7 3.5 0.3% 90.9%
29 OA-AL2i4 (R) OA 7 3.5 0.3% 91.2%
30 Cm3 (R) GABA 6 3.0 0.3% 91.5%
31 Cm31a (R) GABA 6 3.0 0.3% 91.8%
32 PLP069 (R) unclear 6 3.0 0.3% 92.1%
33 5-HTPMPV03 (R) 5HT 5 2.5 0.2% 92.4%
34 aMe17b (R) GABA 5 2.5 0.2% 92.6%
35 Cm11a (R) ACh 5 2.5 0.2% 92.8%
36 LPT51 (R) Glu 5 2.5 0.2% 93.1%
37 MeTu3b (R) ACh 5 2.5 0.2% 93.3%
38 MeVP1 (R) ACh 5 2.5 0.2% 93.6%
39 MeVPMe6 (L) Glu 5 2.5 0.2% 93.8%
40 aMe3 (R) Glu 4 2.0 0.2% 94.0%
41 Cm34 (R) Glu 4 2.0 0.2% 94.2%
42 MeVC22 (R) Glu 4 2.0 0.2% 94.4%
43 MeVP2 (R) ACh 4 2.0 0.2% 94.6%
44 MeVPMe11 (L) Glu 4 2.0 0.2% 94.8%
45 Tm5c (R) Glu 4 2.0 0.2% 95.0%
46 Cm27 (R) Glu 3 1.5 0.1% 95.1%
47 Cm28 (R) unclear 3 1.5 0.1% 95.2%
48 Cm7 (R) Glu 3 1.5 0.1% 95.4%
49 Cm9 (R) Glu 3 1.5 0.1% 95.5%
50 Dm11 (R) Glu 3 1.5 0.1% 95.7%
51 MeVP16 (R) Glu 3 1.5 0.1% 95.8%
52 MeVPaMe2 (L) Glu 3 1.5 0.1% 96.0%
53 MeVPMe3 (L) Glu 3 1.5 0.1% 96.1%
54 OA-AL2i3 (R) OA 3 1.5 0.1% 96.2%
55 SLP250 (R) unclear 3 1.5 0.1% 96.4%
56 Tm26 (R) ACh 3 1.5 0.1% 96.5%
57 Tm38 (R) ACh 3 1.5 0.1% 96.7%
58 TmY10 (R) ACh 3 1.5 0.1% 96.8%
59 5-HTPMPV03 (L) 5HT 2 1.0 0.1% 96.9%
60 aMe17c (R) Glu 2 1.0 0.1% 97.0%
61 aMe4 (R) ACh 2 1.0 0.1% 97.1%
62 Cm11c (R) ACh 2 1.0 0.1% 97.2%
63 Cm29 (R) GABA 2 1.0 0.1% 97.3%
64 Dm4 (R) Glu 2 1.0 0.1% 97.4%
65 LoVCLo3 (R) OA 2 1.0 0.1% 97.5%
66 MeLo6 (R) ACh 2 1.0 0.1% 97.6%
67 MeVP6 (R) Glu 2 1.0 0.1% 97.7%
68 Mi1 (R) ACh 2 1.0 0.1% 97.8%
69 Mi18 (R) GABA 2 1.0 0.1% 97.9%
70 SLP249 (R) unclear 2 1.0 0.1% 98.0%
71 Tm12 (R) ACh 2 1.0 0.1% 98.1%
72 Tm31 (R) Glu 2 1.0 0.1% 98.2%
73 Tm37 (R) Glu 2 1.0 0.1% 98.3%
74 TmY5a (R) Glu 2 1.0 0.1% 98.4%

Outputs

  instance NT total connections connections /#aMe17b (R) % % cumu.
0 Dm8a (R) Glu 2,970 1,485.0 32.6% 32.6%
1 Tm5a (R) ACh 1,631 815.5 17.9% 50.5%
2 Cm31b (R) GABA 891 445.5 9.8% 60.2%
3 Tm5b (R) ACh 768 384.0 8.4% 68.7%
4 Dm8b (R) Glu 558 279.0 6.1% 74.8%
5 MeTu3c (R) ACh 326 163.0 3.6% 78.4%
6 Tm40 (R) ACh 238 119.0 2.6% 81.0%
7 MeTu3b (R) ACh 164 82.0 1.8% 82.8%
8 MeVP57 (R) unclear 100 50.0 1.1% 83.9%
9 MeVP43 (R) ACh 94 47.0 1.0% 84.9%
10 MeTu1 (R) ACh 75 37.5 0.8% 85.7%
11 MeVP2 (R) ACh 74 37.0 0.8% 86.5%
12 MeVPMe13 (R) ACh 58 29.0 0.6% 87.2%
13 Tm5Y (R) ACh 54 27.0 0.6% 87.8%
14 Cm26 (R) Glu 52 26.0 0.6% 88.3%
15 MeVPMe3 (R) Glu 52 26.0 0.6% 88.9%
16 Tm37 (R) Glu 50 25.0 0.5% 89.5%
17 aMe12 (R) ACh 43 21.5 0.5% 89.9%
18 MeVC22 (R) Glu 41 20.5 0.4% 90.4%
19 MeVPLo2 (R) ACh 41 20.5 0.4% 90.8%
20 MeVP14 (R) ACh 37 18.5 0.4% 91.2%
21 MeVP25 (R) unclear 37 18.5 0.4% 91.6%
22 Tm39 (R) ACh 35 17.5 0.4% 92.0%
23 MeVPMe6 (R) Glu 34 17.0 0.4% 92.4%
24 Cm17 (R) GABA 33 16.5 0.4% 92.8%
25 MeVP7 (R) ACh 29 14.5 0.3% 93.1%
26 MeTu4d (R) ACh 28 14.0 0.3% 93.4%
27 aMe25 (R) unclear 26 13.0 0.3% 93.7%
28 Mi4 (R) GABA 24 12.0 0.3% 93.9%
29 T2a (R) ACh 24 12.0 0.3% 94.2%
30 PLP069 (R) unclear 23 11.5 0.3% 94.4%
31 MeVP32 (R) ACh 18 9.0 0.2% 94.6%
32 MeVPMe11 (R) Glu 17 8.5 0.2% 94.8%
33 aMe9 (R) ACh 16 8.0 0.2% 95.0%
34 Cm3 (R) GABA 16 8.0 0.2% 95.2%
35 Lat3 (R) unclear 16 8.0 0.2% 95.4%
36 MeLo3b (R) ACh 16 8.0 0.2% 95.5%
37 Tm24 (R) ACh 16 8.0 0.2% 95.7%
38 MeLo6 (R) ACh 13 6.5 0.1% 95.9%
39 Tm33 (R) ACh 13 6.5 0.1% 96.0%
40 TmY18 (R) ACh 13 6.5 0.1% 96.1%
41 Tm38 (R) ACh 12 6.0 0.1% 96.3%
42 Cm21 (R) GABA 11 5.5 0.1% 96.4%
43 MeVC20 (R) Glu 11 5.5 0.1% 96.5%
44 Cm1 (R) ACh 10 5.0 0.1% 96.6%
45 MeVP15 (R) ACh 10 5.0 0.1% 96.7%
46 MeVPMe4 (R) Glu 10 5.0 0.1% 96.8%
47 Tm29 (R) Glu 10 5.0 0.1% 97.0%
48 MeVP56 (R) unclear 9 4.5 0.1% 97.0%
49 MeVP9 (R) ACh 9 4.5 0.1% 97.1%
50 MeVPMe5 (R) Glu 9 4.5 0.1% 97.2%
51 aMe5 (R) ACh 8 4.0 0.1% 97.3%
52 LA_ME_unclear (R) ACh 8 4.0 0.1% 97.4%
53 MeVPMe6 (L) Glu 8 4.0 0.1% 97.5%
54 Tm36 (R) ACh 8 4.0 0.1% 97.6%
55 MeLo3a (R) ACh 7 3.5 0.1% 97.7%
56 MeVP8 (R) ACh 7 3.5 0.1% 97.8%
57 Tm32 (R) Glu 7 3.5 0.1% 97.8%
58 Tm5c (R) Glu 7 3.5 0.1% 97.9%
59 aMe17a (R) Glu 6 3.0 0.1% 98.0%
60 Cm31a (R) GABA 6 3.0 0.1% 98.0%
61 Cm34 (R) Glu 6 3.0 0.1% 98.1%
62 MeVP6 (R) Glu 6 3.0 0.1% 98.2%
63 Tm12 (R) ACh 6 3.0 0.1% 98.2%
64 aMe17b (R) GABA 5 2.5 0.1% 98.3%
65 MeVP30 (R) ACh 5 2.5 0.1% 98.3%
66 MeVPMe2 (R) Glu 5 2.5 0.1% 98.4%
67 R7y (R) His 5 2.5 0.1% 98.5%
68 Tm20 (R) ACh 5 2.5 0.1% 98.5%
69 Cm11a (R) ACh 4 2.0 0.0% 98.6%
70 Cm2 (R) ACh 4 2.0 0.0% 98.6%
71 Cm7 (R) Glu 4 2.0 0.0% 98.6%
72 Cm9 (R) Glu 4 2.0 0.0% 98.7%
73 Dm2 (R) ACh 4 2.0 0.0% 98.7%
74 Dm9 (R) Glu 4 2.0 0.0% 98.8%
75 MeVP10 (R) ACh 4 2.0 0.0% 98.8%
76 MeVP45 (R) ACh 4 2.0 0.0% 98.9%
77 MeVP47 (R) unclear 4 2.0 0.0% 98.9%
78 MeVP52 (R) ACh 4 2.0 0.0% 98.9%
79 TmY21 (R) ACh 4 2.0 0.0% 99.0%
80 aMe17c (R) Glu 3 1.5 0.0% 99.0%
81 Cm4 (R) Glu 3 1.5 0.0% 99.1%
82 Dm-DRA2 (R) Glu 3 1.5 0.0% 99.1%
83 MeVP1 (R) ACh 3 1.5 0.0% 99.1%
84 MeVP21 (R) ACh 3 1.5 0.0% 99.2%
85 MeVP24 (R) unclear 3 1.5 0.0% 99.2%
86 Mi1 (R) ACh 3 1.5 0.0% 99.2%
87 TmY10 (R) ACh 3 1.5 0.0% 99.3%
88 TmY14 (R) Glu 3 1.5 0.0% 99.3%
89 aMe4 (R) ACh 2 1.0 0.0% 99.3%
90 Cm11b (R) ACh 2 1.0 0.0% 99.3%
91 Cm19 (R) GABA 2 1.0 0.0% 99.4%
92 Cm27 (R) Glu 2 1.0 0.0% 99.4%
93 Dm-DRA1 (R) Glu 2 1.0 0.0% 99.4%
94 Dm20 (R) Glu 2 1.0 0.0% 99.4%
95 MeLo13 (R) Glu 2 1.0 0.0% 99.4%
96 MeVP11 (R) ACh 2 1.0 0.0% 99.5%
97 MeVP29 (R) ACh 2 1.0 0.0% 99.5%
98 MeVP36 (R) unclear 2 1.0 0.0% 99.5%
99 MeVP49 (R) unclear 2 1.0 0.0% 99.5%
100 MeVPaMe2 (R) Glu 2 1.0 0.0% 99.6%
101 OLVC2 (L) GABA 2 1.0 0.0% 99.6%
102 Tm35 (R) Glu 2 1.0 0.0% 99.6%
103 TmY13 (R) ACh 2 1.0 0.0% 99.6%
104 TmY5a (R) Glu 2 1.0 0.0% 99.6%